As a prognostic biomarker of clear cell renal cell carcinoma RUFY4 predicts immunotherapy responsiveness in a PDL1-related manner

Abstract Background Clear cell renal cell carcinoma (ccRCC) is one of the most lethal malignancies in the urinary system and the existing immunotherapy has not achieved satisfactory outcomes. Therefore, this study aims at establishing a novel gene signature for immune infiltration and clinical outco...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Daojia Miao, Jian Shi, Zhiyong Xiong, Wen Xiao, Xiangui Meng, Qingyang Lv, Kairu Xie, Hongmei Yang, Xiaoping Zhang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2022-02-01
coleção:	Cancer Cell International
Assuntos:	Clear cell renal cell carcinoma Immune infiltration Immunotherapy PD-1 blockade Prognostic signatures
Acesso em linha:	https://doi.org/10.1186/s12935-022-02480-7
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!